As Lucky Strike (NYSE:LUCK) prepares to release its Q4 results, investors are weighing its recent outperformance against a history of revenue misses and a slumping stock price. Here's the breakdown ahead of the bell.
Universal Technical Institute (NYSE: UTI) is scheduled to release its fourth-quarter earnings after Wednesday's market close. Investors are watching for signs of sustained growth in the vocational education sector as economic conditions shift.
With Advanced Micro Devices set to report Q4 results, derivatives traders are pricing in a significant post-earnings move, betting the chipmaker's momentum can extend its recent 25% surge from yearly lows.
Palantir Technologies shatters expectations with Q4 results, reporting a 70% revenue surge and forecasting continued robust growth, as its AI platform becomes a central driver for U.S. commercial business.
Following robust Q4 2025 results, Hess Midstream (HESM) is capturing investor interest with increased distributions and a leaner capital expenditure outlook. This financial discipline, set against a volatile energy backdrop, has analysts scrutinizing whether the stock's current price fully reflects its future potential.
Columbia Financial (NASDAQ: CLBK) reported fourth-quarter revenue that significantly exceeded Wall Street expectations, driven by a 247% year-over-year surge. The community bank's performance highlights strengthening net interest income and an accelerating tangible book value.
Mortgage insurance provider MGIC Investment Corp. (NYSE: MTG) reported fourth-quarter revenue that missed analyst expectations, highlighting challenges in a cooling housing market. While earnings per share met consensus, flat year-over-year sales growth disappointed investors.
The professional staffing firm Kforce (NYSE:KFRC) reported fourth-quarter sales that edged past analyst expectations, yet its stock plunged 11.7% as earnings per share fell sharply short of estimates, highlighting ongoing challenges in a tightening labor market.
Capital Southwest Corporation (NASDAQ: CSWC) reported strong fourth-quarter revenue growth of 18.2%, surpassing Wall Street expectations. However, the business development company's GAAP earnings per share came in modestly below analyst consensus estimates.
The data analytics firm smashed Wall Street forecasts for the fourth quarter, reporting a 70% revenue surge to $1.4 billion, driven by explosive growth in its U.S. operations. Its bullish outlook for 2025 further signals resilience amid sector-wide anxieties.
The payments giant reported a 15% jump in revenue, beating Wall Street estimates, as it positions itself to capitalize on emerging trends in stablecoins and AI-driven commerce.
Synthetic biology leader Twist Bioscience reported strong Q1 FY2026 results, with revenue climbing 17% year-over-year to $103.7 million. Management highlighted accelerating demand from AI-powered drug discovery and reiterated its path to adjusted EBITDA breakeven by Q4 FY2026.
While Disney's latest earnings surpassed expectations, investor focus shifted sharply to reports of an accelerated CEO succession timeline, sending the stock lower despite robust performance in streaming and theme parks.
As Amgen prepares to report earnings, analysts are divided on the stock's trajectory. While strategic acquisitions and a solid track record fuel optimism, looming competitive pressures and a key pipeline wait temper expectations.
A major court judgment tied to a 2021 fatal collision, alongside other vehicle incidents, severely impacted Landstar's fourth-quarter profits, compounding pressures from skyrocketing insurance premiums.
The energy giant reported industry-leading earnings and cash flow, driven by record production and deep cost cuts, while returning billions to shareholders and outlining an ambitious growth plan through 2030.
Revvity (NYSE: RVTY) surged past fourth-quarter expectations and issued an upbeat 2026 outlook, driven by robust demand in its diagnostics division. The medical equipment maker's performance highlights a sector-wide resilience despite ongoing softness in academic research funding.
Insurance brokerage giant Brown & Brown sees a key price target cut to $81 following its fourth-quarter earnings, which revealed robust fee growth but concerns over slowing organic revenue expansion.
Northwest Bancshares' Q4 results showcased the initial impact of its Penns Woods acquisition, boosting revenue and margins. While management struck a confident tone on integration, analyst questions during the earnings call revealed a sharper focus on the sustainability of growth, cost savings, and competitive pressures in a shifting rate environment.
Bank of Hawaii delivered a robust fourth quarter, but the real story emerged during the analyst Q&A. We examine the critical questions on margins, deposits, and the bank's strategy in a shifting economic landscape.
